We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Consensus and Guidelines · October 26, 2020

Infection Risk in Patients With MS Treated With Disease-Modifying Therapies

Multiple Sclerosis (Houndmills, Basingstoke, England)


Additional Info

Disclosure statements are available on the authors' profiles:

Multiple Sclerosis (Houndmills, Basingstoke, England)
The Risk of Infection in Patients With Multiple Sclerosis Treated With Disease-Modifying Therapies: A Delphi Consensus Statement
Mult. Scler. 2020 Sep 17;[EPub Ahead of Print], L Moiola, V Barcella, S Benatti, M Capobianco, R Capra, P Cinque, G Comi, MM Fasolo, F Franzetti, M Galli, S Gerevini, L Meroni, M Origoni, L Prosperini, M Puoti, C Scarpazza, C Tortorella, M Zaffaroni, A Riva

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading